Company Profiles

driven by the PitchBook Platform

NeuroGenetic Pharmaceuticals

Description

Developer of drugs for the prevention of neurodegenerative conditions designed to treat Alzheimer's disease. The company's patented technology of Gamma-Secretase Modulators (GSMs) is based on an innovative modulation of a key enzyme in the amyloid pathway, called γ-secretase, enabling patients to start their treatment before the onset of dementia.

2009

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$5M

Latest Deal Amount

$4.4M

Total Amount Raised

Description

Developer of drugs for the prevention of neurodegenerative conditions designed to treat Alzheimer's disease. The company's patented technology of Gamma-Secretase Modulators (GSMs) is based on an innovative modulation of a key enzyme in the amyloid pathway, called γ-secretase, enabling patients to start their treatment before the onset of dementia.

Website:

www.neurogeneticpharmaceuticals.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

445 Marine View Avenue Suite 101 Del Mar, CA 92014United States +1 (858) 461-4480
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NeuroGenetic Pharmaceuticals's full profile, request a free trial.

NeuroGenetic Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NeuroGenetic Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NeuroGenetic Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AbbVie VenturesCorporate Venture CapitalMinority000 0000000 0000
National Institute of Aging (NIA)Other000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
AbbVie Ventures Corporate Venture Capital
National Institute of Aging (NIA) Other
National Institutes of Health Government

NeuroGenetic Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
William Comer Ph.DCo-Founder, Chairman & Chief Executive Officer
Rudolph Tanzi Ph.DCo-Founder
Steven WagnerCo-Founder
Janet McCleanManager, Finance
Maria Kounnas Ph.DSenior Vice President, Research
William Comer Ph.D Co-Founder, Chairman & Chief Executive Officer
Rudolph Tanzi Ph.D Co-Founder
Steven Wagner Co-Founder
Janet McClean Manager, Finance
Maria Kounnas Ph.D Senior Vice President, Research

NeuroGenetic Pharmaceuticals Board Members (3)

NameRepresentingRoleSinceContact
Info
Barry QuartSelfBoard Member000 0000
Thomas ReedSelfBoard Member000 0000
William Comer Ph.DNeuroGenetic PharmaceuticalsCo-Founder, Chairman & Chief Executive Officer000 0000
Barry Quart Board Member Self
Thomas Reed Board Member Self
William Comer Ph.D Co-Founder, Chairman & Chief Executive Officer NeuroGenetic Pharmaceuticals
Request full access to PitchBook